Gel receives U.S. patent for prevention of herpes, HIV
(Gerson Lehrman Group) UPDATED 2009-09-29
Drugmaker Starpharma has received a U.S. patent for the use of its VivaGel vaginal microbicide gel as a preventative treatment for genital herpes and HIV. The gel is designed to give women an inexpensive and easy way to protect themselves from contracting these sexually transmitted infections.
Read full story >
See all Genital Herpes News